Anti-Müllerian hormone serves as a biomarker of the remaining follicular pool and ovarian function. Its value comes from interpreting it as part of a broader assessment rather than as an isolated measure. When considered with basal follicle-stimulating hormone levels and antral follicle counts, it helps characterize ovarian reserve in relation to follicle recruitment and depletion.
Basal follicle-stimulating hormone levels provide endocrine information about ovarian function. Their interpretation complements measurements that describe the follicular population, allowing clinicians and researchers to relate hormonal regulation to follicle growth and depletion. This combined perspective is useful because ovarian reserve assessment examines both biological markers and the developmental processes that shape reproductive aging.
The antral follicle count reflects the population of developing follicles visible during ovarian assessment. It therefore connects a measurable ovarian feature with follicle recruitment and growth, rather than describing endocrine regulation alone. In developmental biology, this count helps researchers examine how the pool of follicles changes over time and contributes to estimates of remaining ovarian reserve.
Ovarian reserve estimates primarily describe the quantity of remaining follicles and oocytes. They do not directly measure oocyte quality, nor do they determine whether pregnancy will occur. This distinction prevents overinterpretation of a reserve result: the assessment can inform reproductive counseling and planning while leaving other determinants of reproductive outcome unresolved.
The evaluation combines anti-Müllerian hormone and basal follicle-stimulating hormone measurements with ultrasound-based antral follicle counting. These measures provide complementary information about endocrine regulation, ovarian function, and the developing follicle population. Considering them together produces a broader reserve estimate than relying on a single indicator and supports more informed interpretation of ovarian status.
Clinicians can use the results to support fertility counseling and to plan assisted reproduction. The findings help describe the remaining follicular resource and ovarian function, which can inform discussions about reproductive potential and treatment planning. They should be presented as reserve estimates, however, rather than direct predictions of oocyte quality or pregnancy success.
In developmental biology, these measurements provide a way to relate follicle recruitment, growth, and depletion to endocrine regulation and reproductive aging. The assessment therefore connects clinical observations with changes in the ovarian follicle pool across reproductive life. It also supports research on ovarian development by linking measurable biomarkers and follicle counts with ovarian function.